Qualcomm, Novartis To Invest In Mobile Health, Aggregate Trial Data
This article was originally published in The Gray Sheet
Executive Summary
The companies say they are partnering to invest in start-ups that have potential to change healthcare delivery and are using Qualcomm’s 2net Platform in a clinical trial to aggregate patient data and personalize treatments.